Brain receptor switches addiction on, off: study

Findings suggest that enzyme may be manipulated phamalogically to control brain receptor

The discovery of a molecular “addiction switch” in the mammalian brain has the potential to control the addiction process in drug addicts, say U of T researchers.

A study published Jan. 18 in the online edition of Nature Neuroscience finds that a region of the brain called the VTA contains receptors that, when exposed to a certain enzyme, can control the switch from an addicted to non-addicted state and back again. This goes against previous ideas that viewed drug addiction as a permanent change in the brain, says lead author Steven Laviolette who conducted the research while a PhD student at U of T’s Department of Anatomy and Cell Biology with senior author Professor Derek van der Kooy.

“Our findings suggest that instead of a permanent alteration in the brain, there’s actually a switch that goes on between two separate systems (one that mediates the brain’s response to drugs while not yet addicted and the other that mediates response once addicted),” says Laviolette. “They also suggest we may be able to manipulate that switch pharmacologically to take drug addicts back to a non-addicted state in a relatively short period of time so they do not crave the drug.”

The switch is a brain receptor known as GABA-A; an enzyme – carbonic anhydrase – produced by the body controls how the receptor behaves. In studies with rats, the researchers were able to manipulate the enzyme with a drug to control whether it turned this switch on or off. Without such intervention, the brain can switch back to a non-addicted state following a period of withdrawal from drugs – a process often measured in weeks. By manipulating the enzyme pharmacologically, however, that return to a non-addicted state in rats has been reduced to a matter of hours, says Laviolette, now a post-doctoral fellow at the University of Pittsburgh.

“The same anatomical pathways that we’re manipulating in rats also exist in humans so we hope that this will be applicable to human drug addiction as well,” he says.

Collaborators on the study, funded by the Canadian Institutes of Health Research, included Roger Gallegos and Steven Henriksen of the Scripps Research Institute in California.

Jessica Whiteside is a news services officer with the department of public affairs.

CONTACT:
Steven Laviolette, ph: (412) 624-7332; email: Laviolette@bns.pitt.edu
U of T Public Affairs, ph: (416) 978-5948; email: jessica.whiteside@utoronto.ca

Media Contact

Jessica Whiteside University of Toronto

Alle Nachrichten aus der Kategorie: Studies and Analyses

innovations-report maintains a wealth of in-depth studies and analyses from a variety of subject areas including business and finance, medicine and pharmacology, ecology and the environment, energy, communications and media, transportation, work, family and leisure.

Zurück zur Startseite

Kommentare (0)

Schreib Kommentar

Neueste Beiträge

Key breakthrough towards on-site cancer diagnosis

No stain? No sweat: Terahertz waves can image early-stage breast cancer without staining. A team of researchers at Osaka University, in collaboration with the University of Bordeaux and the Bergonié…

A CNIO team describes how a virus can cause diabetes

It has recently been described that infection by some enteroviruses – a genus of viruses that commonly cause diseases of varying severity – could potentially trigger diabetes, although its direct…

Targeting the shell of the Ebola virus

UD research team looking at ways to destabilize virus, knock it out with antivirals. As the world grapples with the coronavirus (COVID-19) pandemic, another virus has been raging again in…

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close